The IgG1 isotype of anti-MDA5 antibody may dominate severity of interstitial lung disease in dermatomyositis

被引：0
|
作者：
Chen, M. [1 ]
Zheng, J. [1 ]
Pan, M. [1 ]
Cao, H. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Dept Dermatol, Shanghai, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2020年 / 140卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
903
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [41] Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease
    Gao, Yujuan
    Zhao, Qi
    Xie, Miaomiao
    Yan, Xin
    Li, Yan
    Zhang, Xin
    Wu, Hongyan
    Dai, Jinghong
    Cao, Min
    Cai, Hourong
    CYTOKINE, 2020, 135
  • [42] JUVENILE DERMATOMYOSITIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE: WOULD ANTI-MDA5 ANTIBODY DETECTION IMPROVE EARLY DIAGNOSIS AND MANAGEMENT?
    Gallagher, Kathy
    Bale, Peter
    Armon, Kate
    RHEUMATOLOGY, 2018, 57
  • [43] Prognostic Evaluation of Serum Osteopontin in Patients with Anti-MDA5 Antibody-Positive Dermatomyositis Associated Interstitial Lung Disease
    Gao, Y.
    Zhao, Q.
    Xie, M.
    Zhang, X.
    Wu, H.
    Cai, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [44] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    Ho So
    Victor Tak Lung Wong
    Virginia Weng Nga Lao
    Hin Ting Pang
    Ronald Man Lung Yip
    Clinical Rheumatology, 2018, 37 : 1983 - 1989
  • [45] Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
    Sakamoto, Noriho
    Ishimoto, Hiroshi
    Nakashima, Shota
    Yura, Hirokazu
    Miyamura, Takuto
    Okuno, Daisuke
    Hara, Atsuko
    Kitazaki, Takeshi
    Kakugawa, Tomoyuki
    Ishimatsu, Yuji
    Satoh, Minoru
    Mukae, Hiroshi
    INTERNAL MEDICINE, 2019, 58 (06) : 837 - 841
  • [46] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [47] The lung as a site for the generation of anti-MDA5 antibody in clinically amyopathic dermatomyositis
    Hara, Ryo
    Watanabe, Satoshi
    Terada, Nanao
    Kase, Kazumasa
    Muto, Atsushi
    Hamaguchi, Yasuhito
    Matsushita, Takashi
    Ikeda, Hiroko
    Tanaka, Tomonori
    Yano, Seiji
    RHEUMATOLOGY, 2024,
  • [48] Clinical Features and Prognostic Factors for Dermatomyositis-Associated Interstitial Lung Diseases with Anti-MDA5 Antibody
    Fujisawa, T.
    Hozumi, H.
    Yasui, H.
    Suzuki, Y.
    Karayama, M.
    Furuhashi, K.
    Enomoto, N.
    Nakamura, Y.
    Inui, N.
    Suda, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report
    De Backer, Eva
    Gremonprez, Felix
    Brusselle, Guy
    Depuydt, Pieter
    Van Dorpe, Jo
    Van Haverbeke, Carole
    Goeminne, Pieter C.
    Derom, Eric
    ACTA CLINICA BELGICA, 2018, 73 (06) : 413 - 417
  • [50] INTERSTITIAL LUNG DISEASE IN A PATIENT WITH ANTI-MDA5 AMYOPATHIC DERMATOMYOSITIS, IMPROVED WITH CORTICOSTEROIDS, RITUXIMAB, AND MYCOPHENOLATE
    Haghshenas, Nicole
    Sankari, Layla
    Levitus, Corinne
    Strachan, Paul
    CHEST, 2019, 156 (04) : 1356A - 1357A
12345